文献速递关节外科

基于处方的合并症指数与ASA分级及关节置换术后死亡率的相关性:一项注册研究

Does a Prescription-based Comorbidity Index Correlate with the American Society of Anesthesiologists Physical Status Score and Mortality After Joint Arthroplasty? A Registry Study.
PubMed 文献 · Clin Orthop Relat Res · 2021-01-01

该回顾性注册研究纳入澳大利亚骨科协会国家关节置换注册系统(AOANJRR)中2013至2017年因骨关节炎行初次全髋关节置换术(THA)或全膝关节置换术(TKA)的患者,分析Rx-Risk评分与ASA分级对术后30天和90天死亡率的预测一致性及相关性。结果显示两种评分与死亡率均有较高一致性,但彼此仅呈弱至中度相关,提示Rx-Risk可作为ASA的补充指标。

要点

  • Rx-Risk与ASA评分对THA和TKA术后30天死亡率均有较高预测一致性。
  • 两评分在THA患者中呈中度相关(r=0.45),在TKA患者中呈弱相关(r=0.38)。
  • Rx-Risk评分中位数随ASA分级升高而增加,提示两者反映不同健康维度。

核心结论

  • ASA分级与Rx-Risk评分均与THA和TKA术后30天及90天死亡率相关,但两者仅呈弱至中度相关,Rx-Risk可作为ASA的补充评估工具。

研究设计与样本

  • 回顾性分析澳大利亚骨科协会国家关节置换注册系统(AOANJRR)数据库,并与国家死亡索引(NDI)和药品福利计划(PBS)数据库链接。
  • 纳入2013至2017年因原发性骨关节炎行THA(127,761例手术,116,021例患者)或TKA(210,501例手术,178,350例患者)的病例,排除ASA信息缺失者(THA 3%,TKA 2%)。
  • 采用逻辑回归模型评估ASA与Rx-Risk评分和术后30天及90天死亡率的的一致性,使用Spearman相关系数评估两评分间的相关性,THA和TKA分别分析。

主要发现

  • THA术后30天死亡率一致性:ASA的c统计量为0.83(95% CI 0.79-0.86),Rx-Risk为0.82(95% CI 0.79-0.86)。
  • TKA术后30天死亡率一致性:ASA的c统计量为0.73(95% CI 0.69-0.78),Rx-Risk为0.74(95% CI 0.70-0.79)。
  • THA患者中两评分相关系数r=0.45,TKA患者中r=0.38;Rx-Risk评分中位数随ASA分级升高而增加(THA:ASA 1-4对应中位数1、3、5、7;TKA:对应2、4、5、7)。

关键数值与推荐

  • Rx-Risk评分范围为0至47分,用于衡量个体因不同健康状况接受治疗的数量。
  • ASA分级与Rx-Risk评分对THA和TKA术后30天死亡率均显示出较高一致性(c统计量0.73-0.83)。

临床怎么用

  • 在关节置换术前风险评估中,可考虑将Rx-Risk评分作为ASA分级的补充工具,以更全面反映患者合并症负担。
  • Rx-Risk评分基于处方数据自动获取,可能便于注册系统或电子病历中的风险分层。

局限性

  • 本研究为回顾性注册数据分析,可能存在未测量的混杂因素。
  • 仅纳入因骨关节炎行初次THA或TKA的患者,结论外推需谨慎。
  • ASA信息缺失者被排除(THA 3%,TKA 2%),可能引入选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When analyzing the outcomes of joint arthroplasty, an important factor to consider is patient comorbidities. The presence of multiple comorbidities has been associated with longer hospital stays, more postoperative complications, and increased mortality. The American Society of Anesthesiologists (ASA) physical status classification system score is a measure of a patient's overall health and has been shown to be associated with complications and mortality after joint arthroplasty. The Rx-Risk score is another measure for determining the number of different health conditions for which an individual is treated, with a possible score ranging from 0 to 47. QUESTIONS/PURPOSES: For patients undergoing THA or TKA, we asked: (1) Which metric, the Rx-Risk score or the ASA score, correlates more closely with 30- and 90-day mortality after TKA or THA? (2) Is the Rx-Risk score correlated with the ASA score? METHODS: This was a retrospective analysis of the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) database linked to two other national databases, the National Death Index (NDI) database and the Pharmaceutical Benefits Scheme (PBS), a dispensing database. Linkage to the NDI provided outcome information on patient death, including the fact of and date of death. Linkage to the PBS was performed to obtain records of all medicines dispensed to patients undergoing a joint replacement procedure. Patients were included if they had undergone either a THA (119,076 patients, 131,336 procedures) or TKA (182,445 patients, 215,712 procedures) with a primary diagnosis of osteoarthritis, performed between 2013 and 2017. We excluded patients with missing ASA information (THA: 3% [3055 of 119,076]; TKA: 2% [4095 of 182,445]). This left 127,761 primary THA procedures performed in 116,021 patients (53% [68,037 of 127,761] were women, mean age 68 ± 11 years) and 210,501 TKA procedures performed in 178,350 patients (56% [117,337 of 210,501] were women, mean age 68 ± 9 years) included in this study. Logistic regression models were used to determine the concordance of the ASA and Rx-Risk scores and 30-day and 90-day postoperative mortality. The Spearman correlation coefficient (r) was used to estimate the correlation between the ASA score and Rx-Risk score. All analyses were performed separately for THAs and TKAs. RESULTS: We found both the ASA and Rx-Risk scores had high concordance with 30-day mortality after THA (ASA: c-statistic 0.83 [95% CI 0.79 to 0.86]; Rx-Risk: c-statistic 0.82 [95% CI 0.79 to 0.86]) and TKA (ASA: c-statistic 0.73 [95% CI 0.69 to 0.78]; Rx-Risk: c-statistic 0.74 [95% CI 0.70 to 0.79]). Although both scores were strongly associated with death, their correlation was moderate for patients undergoing THA (r = 0.45) and weak for TKA (r = 0.38). However, the median Rx-Risk score did increase with increasing ASA score. For example, for THAs, the median Rx-Risk score was 1, 3, 5, and 7 for ASA scores 1, 2, 3, and 4, respectively. For TKAs, the median Rx-Risk score was 2, 4, 5, and 7 for ASA scores 1, 2, 3, and 4, respectively. CONCLUSION: The ASA physical status and RxRisk were associated with 30-day and 90-day mortality; however, the scores were only weakly to moderately correlated with each other. This suggests that although both scores capture a similar level of patient illness, each score may be capturing different aspects of health. The Rx-Risk may be used as a complementary measure to the ASA score. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Kerr MM, Graves SE, Duszynski KM, et al. Does a Prescription-based Comorbidity Index Correlate with the American Society of Anesthesiologists Physical Status Score and Mortality After Joint Arthroplasty? A Registry Study. Clin Orthop Relat Res. 2021. PMID: 34232146. doi:10.1097/CORR.0000000000001895

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。